Cargando…

Optimizing biomarkers for accurate ependymoma diagnosis, prognostication, and stratification within International Clinical Trials: A BIOMECA study

BACKGROUND: Accurate identification of brain tumor molecular subgroups is increasingly important. We aimed to establish the most accurate and reproducible ependymoma subgroup biomarker detection techniques, across 147 cases from International Society of Pediatric Oncology (SIOP) Ependymoma II trial...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chapman, Rebecca J, Ghasemi, David R, Andreiuolo, Felipe, Zschernack, Valentina, Espariat, Arnault Tauziede, Buttarelli, Francesca R, Giangaspero, Felice, Grill, Jacques, Haberler, Christine, Paine, Simon M L, Scott, Ian, Jacques, Thomas S, Sill, Martin, Pfister, Stefan, Kilday, John-Paul, Leblond, Pierre, Massimino, Maura, Witt, Hendrik, Modena, Piergiorgio, Varlet, Pascale, Pietsch, Torsten, Grundy, Richard G, Pajtler, Kristian W, Ritzmann, Timothy A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Pediatric Neuro-Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10547510/ https://www.ncbi.nlm.nih.gov/pubmed/36916248 http://dx.doi.org/10.1093/neuonc/noad055

Ejemplares similares

EPEN-24. Biological markers of ependymoma in children and adolescents (BIOMECA): Systematic comparison of methods for the precise evaluation of biomarkers for ependymoma diagnosis and prognostication
por: Chapman, Rebecca, et al.
Publicado: (2022)

EPEN-02. OPTIMISING BIOMARKERS FOR ACCURATE EPENDYMOMA DIAGNOSIS, PROGNOSTICATION AND STRATIFICATION WITHIN INTERNATIONAL CLINICAL TRIALS: A BIOMECA STUDY
por: Chapman, Rebecca J, et al.
Publicado: (2023)

SIOP Ependymoma I: Final results, long-term follow-up, and molecular analysis of the trial cohort—A BIOMECA Consortium Study
por: Ritzmann, Timothy A, et al.
Publicado: (2022)

EPEN-04. SIOP EPENDYMOMA I: FINAL RESULTS, LONG TERM FOLLOW-UP AND MOLECULAR ANALYSIS OF THE TRIAL COHORT: A BIOMECA CONSORTIUM STUDY
por: A. Ritzmann, Timothy, et al.
Publicado: (2021)

WHO grade has no prognostic value in the pediatric high-grade glioma included in the HERBY trial
por: Varlet, Pascale, et al.
Publicado: (2020)

Diagnostics of pediatric supratentorial RELA ependymomas: integration of information from histopathology, genetics, DNA methylation and imaging
por: Pagès, Mélanie, et al.
Publicado: (2018)

Role of neoadjuvant chemotherapy in metastatic medulloblastoma: a comparative study in 92 children
por: Guerrini-Rousseau, Léa, et al.
Publicado: (2020)

Integrating Tenascin-C protein expression and 1q25 copy number status in pediatric intracranial ependymoma prognostication: A new model for risk stratification
por: Andreiuolo, Felipe, et al.
Publicado: (2017)

Pediatric ependymomas: destined to recur?
por: Ritzmann, Timothy A, et al.
Publicado: (2021)

NF2 and ZFTA evaluation in the diagnostic algorithm of pediatric posterior fossa ependymoma with H3K27ME3 retained expression
por: Tauziède-Espariat, Arnault, et al.
Publicado: (2023)

Posterior fossa ependymoma H3 K27-mutant: an integrated radiological and histomolecular tumor analysis
por: Mariet, Cassandra, et al.
Publicado: (2022)

EZHIP is a specific diagnostic biomarker for posterior fossa ependymomas, group PFA and diffuse midline gliomas H3-WT with EZHIP overexpression
por: Antin, C., et al.
Publicado: (2020)

Histopathological grading of pediatric ependymoma: reproducibility and clinical relevance in European trial cohorts
por: Ellison, David W, et al.
Publicado: (2011)

Toward Improved Diagnosis Accuracy and Treatment of Children, Adolescents, and Young Adults With Ependymoma: The International SIOP Ependymoma II Protocol
por: Leblond, Pierre, et al.
Publicado: (2022)

EPEN-05. Adenosine receptor expression in paediatric ependymoma
por: Spanoudakis, Chelsea, et al.
Publicado: (2022)

Mesenchymal non-meningothelial tumors of the central nervous system: a literature review and diagnostic update of novelties and emerging entities
por: Tauziède-Espariat, Arnault, et al.
Publicado: (2023)

Supratentorial non-RELA, ZFTA-fused ependymomas: a comprehensive phenotype genotype correlation highlighting the number of zinc fingers in ZFTA-NCOA1/2 fusions
por: Tauziède-Espariat, Arnault, et al.
Publicado: (2021)

Childhood supratentorial ependymomas with YAP1‐MAMLD1 fusion: an entity with characteristic clinical, radiological, cytogenetic and histopathological features
por: Andreiuolo, Felipe, et al.
Publicado: (2018)

NF1-like optic pathway gliomas in children: clinical and molecular characterization of this specific presentation
por: Lobón-Iglesias, María Jesús, et al.
Publicado: (2019)

Portrait of Ependymoma Recurrence in Children: Biomarkers of Tumor Progression Identified by Dual-Color Microarray-Based Gene Expression Analysis
por: Peyre, Matthieu, et al.
Publicado: (2010)

Papillary glioneuronal tumors: histological and molecular characteristics and diagnostic value of SLC44A1-PRKCA fusion
por: Pages, Melanie, et al.
Publicado: (2015)

The genomic landscape of dysembryoplastic neuroepithelial tumours and a comprehensive analysis of recurrent cases
por: Pagès, Mélanie, et al.
Publicado: (2022)

Unedited microneurosurgery of a fourth ventricular ependymoma
por: Choque-Velasquez, Joham, et al.
Publicado: (2018)

Unedited microneurosurgery of a pineal region ependymoma
por: Choque-Velasquez, Joham, et al.
Publicado: (2018)

Pediatric high-grade glioma MYCN is frequently associated with Li-Fraumeni syndrome
por: Guerrini-Rousseau, Léa, et al.
Publicado: (2023)

Limitations of current in vitro models for testing the clinical potential of epigenetic inhibitors for treatment of pediatric ependymoma
por: Rogers, Hazel Anne, et al.
Publicado: (2018)

Diffusion MRI of the facial-vestibulocochlear nerve complex: a prospective clinical validation study
por: Shapey, Jonathan, et al.
Publicado: (2023)

Prognostic Clinical and Biologic Features for Overall Survival after Relapse in Childhood Medulloblastoma
por: Huybrechts, Sophie, et al.
Publicado: (2020)

Ependymoma: Evaluation and Management Updates
por: Rudà, Roberta, et al.
Publicado: (2022)

Molecular dissection of ependymomas
por: Pajtler, Kristian W., et al.
Publicado: (2015)

Pediatric methylation class HGNET-MN1: unresolved issues with terminology and grading
por: Tauziède-Espariat, Arnault, et al.
Publicado: (2019)

EPEN-03. LONG-TERM FOLLOW-UP OF AIEOP 2ND SERIES OF CHILDREN AND ADOLESCENT WITH PRIMARY INTRACRANIAL (ST:SUPRATENTORIAL; PF: POSTERIOR FOSSA) EPENDYMOMA AND METHYLATION GROUPS RE-ANALYSES
por: Massimino, Maura, et al.
Publicado: (2020)

Ependymomas
por: Bertero, Luca, et al.
Publicado: (2022)

Evaluation of dose, volume, and outcome in children with localized, intracranial ependymoma treated with proton therapy within the prospective KiProReg Study
por: Peters, Sarah, et al.
Publicado: (2021)

EPEN-24. SIOP EPENDYMOMA II: CENTRAL EPENDYMOMA MANAGEMENT ADVISORY GROUP – THE UK EXPERIENCE
por: Macarthur, Donald C, et al.
Publicado: (2020)

Deciphering the genetic and epigenetic landscape of pediatric bithalamic tumors
por: Tauziède‐Espariat, Arnault, et al.
Publicado: (2021)

IMMU-10. TUMOR ASSOCIATED MYELOID CELLS DRIVE THE IMMUNOBIOLOGY OF HIGH RISK PEDIATRIC EPENDYMOMA
por: Griesinger, Andrea, et al.
Publicado: (2022)

DIPG-58. HISTONE H3 WILD-TYPE DIPG/DMG OVEREXPRESSING EZHIP EXTEND THE SPECTRUM OF DIFFUSE MIDLINE GLIOMAS WITH PRC2 INHIBITION BEYOND H3-K27M MUTATION
por: Castel, David, et al.
Publicado: (2020)

Clinical and molecular analysis of smoothened inhibitors in Sonic Hedgehog medulloblastoma
por: Pereira, Victor, et al.
Publicado: (2021)

Pediatric meningiomas: A literature review and diagnostic update
por: Tauziède-Espariat, Arnault, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_lgjacfotks4rrbi3j0on0dt0j5